• Top
• Abstract
• Background
• Methods
• Results and discussion
• Conclusion
• Authors' contributions
• Acknowledgements
• References

Research

The 10 kDa domain of human erythrocyte protein 4.1 binds the Plasmodium falciparum EBA-181 protein

Roberto Lanzillotti and Theresa L Coetzer

Department of Molecular Medicine and Haematology, National Health Laboratory Service, School of Pathology, University of the Witwatersrand, Parktown, Johannesburg, 2193, South Africa

author email corresponding author email

Malaria Journal 2006, 5:100doi:10.1186/1475-2875-5-100

The electronic version of this article is the complete one and can be found online at: http://www.malariajournal.com/content/5/1/100

Received:	29 June 2006
Accepted:	6 November 2006
Published:	6 November 2006

© 2006 Lanzillotti and Coetzer; licensee BioMed Central Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Background

Erythrocyte invasion by Plasmodium falciparum parasites represents a key mechanism during malaria pathogenesis. Erythrocyte binding antigen-181 (EBA-181) is an important invasion protein, which mediates a unique host cell entry pathway. A novel interaction between EBA-181 and human erythrocyte membrane protein 4.1 (4.1R) was recently demonstrated using phage display technology. In the current study, recombinant proteins were utilized to define and characterize the precise molecular interaction between the two proteins.

Methods

4.1R structural domains (30, 16, 10 and 22 kDa domain) and the 4.1R binding region in EBA-181 were synthesized in specific Escherichia coli strains as recombinant proteins and purified using magnetic bead technology. Recombinant proteins were subsequently used in blot-overlay and histidine pull-down assays to determine the binding domain in 4.1R.

Results

Blot overlay and histidine pull-down experiments revealed specific interaction between the 10 kDa domain of 4.1R and EBA-181. Binding was concentration dependent as well as saturable and was abolished by heat denaturation of 4.1R.

Conclusion

The interaction of EBA-181 with the highly conserved 10 kDa domain of 4.1R provides new insight into the molecular mechanisms utilized by P. falciparum during erythrocyte entry. The results highlight the potential multifunctional role of malaria invasion proteins, which may contribute to the success of the pathogenic stage of the parasite's life cycle.

Background

Malaria is caused by a group of infectious protozoan parasites that alters the physiological functioning and cellular biology of erythrocytes. Plasmodium falciparum is the best-studied species and is the commonest, most virulent and principal cause of the majority of infections and deaths worldwide. Since the completion of the parasite's genome sequence [1], a wealth of knowledge has been generated through proteomic and genomic studies. High-throughput screening [2,3], protein identification technology such as mass spectrometry [4-7] and gene knockdown/knockout technology [8-13] are some of the methods that have been used to decipher complex molecular processes governing the life cycle of P. falciparum.

The invasion of erythrocytes by P. falciparum initiates the pathogenic phase of the life cycle and is essential for parasite survival and progression of clinical malaria [14]. Invasion is a complex process involving a series of molecular interactions between P. falciparum merozoites and erythrocyte membrane receptors. Mediators of invasion have been identified on the merozoite surface and in organelles of the apical complex, namely rhoptries, micronemes and dense granules. However, the precise functioning of these proteins and mechanisms governing the entry process are poorly understood [15,16].

A family of erythrocyte Duffy binding-like (DBL) proteins, located within the micronemes, plays a crucial role in the binding of merozoites to the host cell. In P. falciparum, six homologous DBL genes have been found, including erythrocyte binding antigen-175 (EBA-175), EBA-181 (JESEBL), EBA-140 (BAEBL), EBA-165 (PEBL), MAEBL and erythrocyte binding ligand-like 1 protein. These genes encode several domains including two cysteine-rich regions. These regions comprise one or two copies of an amino DBL domain which defines the erythrocyte-binding region and a C-terminal domain of unknown function [17]. Each protein encodes unique receptor specificity, which allows P. falciparum to diversify the number of invasion pathways [18].

EBA-181 has been identified on chromosome 1 of the P. falciparum genome. The protein is expressed in merozoites as well as schizonts and evidence suggests that this ligand plays a role during erythrocyte invasion [19,20]. Eight polymorphisms have been found in the erythrocyte binding domains, which have been hypothesized to promote survival advantage in parasites exposed to genetically diverse human populations [21].

Recent work utilizing P. falciparum phage display libraries has identified a protein-protein interaction between erythrocyte membrane protein 4.1 (4.1R) and EBA-181 [22,23]. 4.1R is an important component of the erythrocyte skeleton, which provides mechanical strength to the membrane through vertical interaction with glycophorin C/D and horizontal association with spectrin and actin [24]. The interaction of 4.1R with EBA-181 suggests a new role for this protein at the host-parasite interface. In this study, recombinant proteins were used to map the domain in 4.1R responsible for binding to the parasite protein.

Methods

Preparation of recombinant proteins

Total RNA was extracted from human reticulocytes [25] and the four structural domain sequences of 4.1R (30 kDa, 16 kDa, 10 kDa and 22/24 kDa, Figure 1A) [26-28] were reverse transcribed using AMV reverse transcriptase (Promega, USA). Primers flanking the relevant domains were designed and restriction sites for BamH I or EcoR I and Xho I appended at the 5' and 3' ends respectively (Table 1). The 4.1R cDNA was amplified by polymerase chain reaction (PCR), digested with appropriate restriction enzymes and subcloned into the pGEX-4T-2 protein expression vector (Amersham Biosciences, UK) according to standard methods. The reading frame and PCR product sequences were verified using automated DNA sequencing. 4.1R vector constructs were transfected into Rosetta™ 2 (DE3) Escherichia coli (E. coli) cells (Novagen, USA) and expression of glutathione-S-transferase (GST)-tagged polypeptides induced with either 1 mM isopropyl β-D-thiogalactopyranoside (IPTG) (Invitrogen, USA) or Overnight Express™ Autoinduction System (Novagen, USA). GST-tagged proteins were purified from E. coli extracts using MagneGST™ agarose beads (Promega, USA).

A histidine (6His)-tagged peptide (denoted PfJ) encompassing the 4.1R binding region in EBA-181 was prepared (Figure 1C). P. falciparum was cultured in vitro by the method of Trager and Jensen [29] and genomic DNA extracted using phenol-chloroform and ethanol precipitation. The EBA-181 binding sequence was amplified from parasite DNA by PCR, using primers containing 5' Nde I and 3' BamH I recognition sequences (Table 1). PfJ was subcloned into pET15b vector (Novagen, USA), the insert sequenced and the vector construct transfected into BL21-CodonPlus^® (DE3) RIL competent cells (Stratagene, USA). 6His-PfJ was induced using 1 mM IPTG and purified from E. coli extracts using His-Select™ magnetic agarose beads (Sigma, USA).

Recombinant proteins were dialyzed against PBS (10 mM Na₂HPO₄, 1.5 mM KH₂PO₄, 137 mM NaCl, 2.7 mM KCl, pH 7.4) in a Slide-A-Lyzer MINI dialysis unit (Pierce, USA) for 2 hrs at 8°C. Protein concentrations were determined spectrophotometrically at 595 nm using the Coomassie Plus^® Protein Assay Reagent Kit (Pierce, USA). Protein aliquots were analyzed by 12% sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) and samples stored at -20°C in a final concentration of 1 mM Pefablock^® SC (Roche, Germany).

Blot overlay assays

Blot overlay assays were used for studying protein-protein interactions between recombinant proteins. The objective was to map the interaction between 6His-PfJ and GST-4.1R domains.

Approximately 5 μg of GST, GST-4.1R structural domains and 6His-parasite protein were spotted onto Hybond C nitrocellulose membrane strips (Amersham, UK). Additional binding sites were blocked in 5% BSA in TBS (0.05 M Tris-HCl, 0.9% NaCl, pH 7.5) for 1 hr and the membranes overlaid with 0.5–1 μg of either purified 4.1R [30] or appropriate recombinant domain for 2 hrs. GST and the 4.1R domains served as negative and positive controls respectively. The strips were washed twice for 1 minute each in TBS and the bound protein fixed to the membrane with 0.5% (v/v) formaldehyde in TBS for 20 minutes. Membranes were washed for 15 minutes in TBS and probed with 1:1,000 rabbit anti-4.1R antibody (St. Elizabeth's Medical Centre, Boston, USA) for at least 1 hr. Interactions were detected with 1:1,000 goat anti-rabbit IgG peroxidase conjugated antibody (Roche, Germany) using Supersignal^® West Pico Chemiluminescent substrate (Pierce, USA).

Pull-down assays

Pull-down assays were used to verify the interaction between P. falciparum protein and the specific 4.1R domain. Furthermore, the dependence of the interaction on concentration was determined by densitometric scanning of 12% SDS-PAGE gels.

Approximately 700 ng 6His-PfJ was coupled to 30 μl aliquots of His-Select™ magnetic beads. Various amounts of specific GST-4.1R domain, ranging from 150 ng to 2 μg, as well as 0.5 μg, 5 μg and 10 μg heat denatured protein were added to the beads and incubated for 1 hr at room temperature. The denatured samples served as a control to correct for non-specific binding. The beads were rinsed with TBS and the protein complexes eluted using 1% SDS in TBS for 10 minutes. Samples were analyzed by SDS-PAGE and 12% polyacrylamide gels scanned using a Hoefer transmittance/reflectance scanning densitometer (Hoefer, USA). Areas under the peaks were compared to standard GST-10 kDa and 6His-PfJ curves and the ratio of bound protein (μg) to parasite protein (μg) determined. A curve was plotted against the amount of 4.1R domain to determine whether the interaction was saturable.

Results and discussion

Recombinant proteins

Rosetta 2 (DE3) cells were transformed with the different 4.1R domain constructs and induced with 1 mM IPTG. Under these conditions, the expressed 10 kDa, 16 kDa and 22 kDa recombinant proteins were soluble, while the GST-tagged 30 kDa protein was completely insoluble. The use of the Overnight Express™ Autoinduction system significantly improved the yield of soluble GST-30 kDa. 0.5–1 μg of purified protein was obtained from 1 ml IPTG-induced culture volumes or 25 ml Overnight Express cultures. Scanning densitometry of a 12% SDS polyacrylamide gel revealed that purified proteins were more than 85% pure (Figure 1B). A Western blot was performed to confirm the identity of GST-tagged 4.1R domains (data not shown). 6His-PfJ was expressed predominantly as a soluble protein as evidenced by SDS-PAGE analysis and its identity confirmed with Western blot analysis (data not shown). Approximately 0.8 μg of protein was obtained from 1 ml E. coli culture. 6His-PfJ was purified to more than 95% homogeneity as determined by scanning densitometry. Polyacrylamide gels indicated that PfJ migrated as an apparent dimer (~50 kDa) under SDS-PAGE conditions (Figure 1D). This is most likely attributed to the high proportion of charged amino acids in PfJ, which presumably resulted in atypical binding of SDS molecules leading to aberrant and unpredictable migration patterns on denaturing polyacrylamide gels [31].

6His-PfJ binds the 10 kDa domain of 4.1R

Recombinant proteins were used in blot overlay and histidine pull-down assays to determine the binding site in 4.1R specific for 6His-PfJ. Blot overlay assays showed that 6His-PfJ bound specifically to the GST-10 kDa domain as well as native 4.1R (Figure 2). The recombinant parasite protein did not bind GST nor the 16 kDa, 22 kDa and 30 kDa GST-tagged domains. To confirm the interaction between GST-4.1R fragments and 6His-PfJ, histidine pull-down assays were performed. In agreement with the blot overlay data, GST-10 kDa bound specifically to 6His-PfJ in a dose-dependent manner (Figure 3A). The interaction was abolished by heat denaturation of the 10 kDa domain. Histidine pull-down assays were also performed with GST-16, 22 and 30 kDa proteins and 6His-PfJ. As shown in figure 3B, no binding was detectable in the 30 and 22 kDa reactions. The GST-16 kDa pull-down assay revealed some binding with 6His-PfJ, but this was non-specific as the interaction was comparable to heat-denatured 4.1R domain.

To determine whether the interaction between 6His-PfJ and GST-10 kDa was saturable, the parasite protein was incubated with a concentration range of 10 kDa domain. Scanning densitometry of the polyacrylamide gels revealed that the interaction was concentration dependent and saturable in three independent experiments using different protein preparations (Figure 4A–C). To compensate for non-specific binding, 54 ng heat denatured GST-10 kDa per μg 6His-PfJ was subtracted from the amount of bound protein. This value was determined by averaging the non-specific binding displayed by 0.5 μg and 10 μg of heat denatured 4.1R domain, which was 51 and 58 ng/μg PfJ respectively. This result demonstrated that 6His-PfJ bound specifically to GST-10 kDa. To allow semi-quantitative assessment of the interaction, a rough estimate of the dissociation constant (Kd) was obtained by linear transformations of the three curves which gave an average Kd of 745 nM.

P. falciparum and erythrocyte invasion proteins

The in vitro association of EBA-181 with an underlying erythrocyte skeletal protein has important implications for P. falciparum invasion. 4.1R is a critical component of the erythrocyte skeleton. It functions by stabilizing horizontal protein interactions and links the underlying skeleton to the lipid bilayer [32]. The conserved 10 kDa domain of 4.1R interacts with a number of key proteins, and represents a pivotal point in the control of erythrocyte membrane integrity. The domain facilitates the interaction between spectrin and actin, and in so doing maintains the deformability of the erythrocyte [24]. The 10 kDa region has been shown to bind and regulate myosin activity [33]. Fowler and colleagues [34] proposed that erythrocyte myosin could function together with actin and its associated proteins in an actomyosin contractile apparatus, raising the possibility of an ATP-dependent process responsible for regulating shape transformations in human erythrocytes. Cibert and colleagues [35] explored a potential role for actomyosin complexes in the restoration of erythrocyte membrane skeletons, damaged by mechanical or chemical stress. Their model proposes that upon disruption of the skeletal network, cytosolic myosin is relocated to the erythrocyte bilayer where formation of an actomyosin complex initiates repair of the relevant area. The repair process was suggested to involve a stable linkage of actin protofilaments by myosin filaments around the area of damage. The disruption of linkages between 4.1R, spectrin, actin and myosin, therefore, has serious consequences for the stability and repair of erythrocyte membranes.

Damage inflicted by invading merozoites to the erythrocyte's protein and lipid bilayer, may initiate actomyosin repair processes. This would subsequently lead to the restoration of the damaged areas and provide a barrier for merozoite entry. P. falciparum, having sustained a long-standing association with human hosts, evolved complex evolutionary adaptations to ensure its own survival. It may be conceivable that specific P. falciparum proteins evolved to subvert host membrane repair. The interaction between EBA-181 and the 10 kDa domain of 4.1R may be such a mechanism, whereby EBA-181 blocks the binding of myosin to 4.1R. This prevents the activation of actomyosin repair machinery. As a result, the parasite modulates host cellular processes to guarantee successful invasion.

Binding of the P. falciparum invasion protein, EBA-181, to 4.1R may thus facilitate invasion and prevent repair of the damage to the erythrocyte membrane, prior to parasite entry. Based on published findings from other groups and the EBA-181/4.1R interaction described in this work, the following speculative model of P. falciparum erythrocyte entry is proposed: Following initial attachment to the host cell surface, the merozoite reorients to bring its apical end in close contact with the host membrane [16]. An increase in the parasite's intracellular calcium concentration signals the secretion of the microneme and rhoptry contents onto the erythrocyte surface [36]. With the aid of a C-terminal transmembrane domain, DBL proteins are translocated from the micronemes onto the merozoite surface, where the DBL binding domains interact with erythrocyte receptors [37]. However, it is possible that full-length invasion proteins or modified forms [38,39] interact with the erythrocyte skeleton. This would be made possible through the action of lipases and proteases from the merozoite's apical organelles. These molecules are responsible for initiating structural changes in the erythrocyte membrane including skeletal and surface modifications [31,40-42]. It is therefore likely that the cleavage of proteins and phospholipids on the erythrocyte membrane during invasion will facilitate the transient access of EBA-181 to 4.1R.

Conclusion

The intimate interaction between P. falciparum and the erythrocyte membrane has provided fascinating insight into the cell biology of the malaria parasite. The interaction of EBA-181 with the highly conserved 10 kDa domain in 4.1R highlights the complex role of microneme invasion proteins. These proteins may potentially serve multiple functions to mediate parasite entry into the erythrocyte, including: 1) the initiation of merozoite invasion by binding specific erythrocyte membrane receptors; 2) the destabilization of spectrin-actin interactions and framework of the erythrocyte skeleton as a consequence of binding to 4.1R, and 3) EBA-181 may inhibit potential host membrane repair pathways.

Authors' contributions

RL prepared the recombinant proteins, carried out the molecular interaction studies and drafted the manuscript. TLC was involved in the design and coordination of the study, and assisted in drafting the manuscript. All authors read and approved the final manuscript.

Acknowledgements

We thank the Department of Pharmacy and Pharmacology, University of the Witwatersrand, for supplying stock cultures of P. falciparum (strain FCR-3). This material is based upon work supported by the National Research Foundation under grant number (2069449), as well as research grants from the Medical Research Council of South Africa, National Health Laboratory Service and University of the Witwatersrand.

References

1. Gardner MJ, Hall N, Fung E, White O, Berriman M, Hyman RW, Carlton JM, Pain A, Nelson KE, Bowman S, Paulsen IT, James K, Eisen JA, Rutherford K, Salzberg SL, Craig A, Kyes S, Chan MS, Nene V, Shallom SJ, Suh B, Peterson J, Angiuoli S, Pertea M, Allen J, Selengut J, Haft D, Mather MW, Vaidya AB, Martin DM, Fairlamb AH, Fraunholz MJ, Roos DS, Ralph SA, McFadden GI, Cummings LM, Subramanian GM, Mungall C, Venter JC, Carucci DJ, Hoffman SL, Newbold C, Davis RW, Fraser CM, Barrell B: Genome sequence of the human malaria parasite Plasmodium falciparum.

   Nature 2002, 419(6906):498-511. PubMed Abstract | Publisher Full Text

2. Bozdech Z, Llinas M, Pulliam BL, Wong ED, Zhu J, DeRisi JL: The transcriptome of the intraerythrocytic developmental cycle of Plasmodium falciparum.

   PLoS Biol 2003, 1(1):E5. PubMed Abstract | Publisher Full Text | PubMed Central Full Text

3. Le Roch KG, Zhou Y, Blair PL, Grainger M, Moch JK, Haynes JD, De La Vega P, Holder AA, Batalov S, Carucci DJ, Winzeler EA: Discovery of gene function by expression profiling of the malaria parasite life cycle.

   Science 2003, 301(5639):1503-1508. PubMed Abstract | Publisher Full Text

4. Carucci DJ, Yates JR 3rd, Florens L: Exploring the proteome of Plasmodium.

   Int J Parasitol 2002, 32(13):1539-1542. PubMed Abstract | Publisher Full Text

5. Florens L, Washburn MP, Raine JD, Anthony RM, Grainger M, Haynes JD, Moch JK, Muster N, Sacci JB, Tabb DL, Witney AA, Wolters D, Wu Y, Gardner MJ, Holder AA, Sinden RE, Yates JR, Carucci DJ: A proteomic view of the Plasmodium falciparum life cycle.

   Nature 2002, 419(6906):520-526. PubMed Abstract | Publisher Full Text

6. Lasonder E, Ishihama Y, Andersen JS, Vermunt AM, Pain A, Sauerwein RW, Eling WM, Hall N, Waters AP, Stunnenberg HG, Mann M: Analysis of the Plasmodium falciparum proteome by high-accuracy mass spectrometry.

   Nature 2002, 419(6906):537-542. PubMed Abstract | Publisher Full Text

7. Sowa MP, Sharling L, Humphreys G, Cavanagh DR, Gregory WF, Fenn K, Creasey AM, Arnot DE: High throughput immuno-screening of cDNA expression libraries produced by in vitro recombination; exploring the Plasmodium falciparum proteome.

   Mol Biochem Parasitol 2004, 133(2):267-274. PubMed Abstract | Publisher Full Text

8. Carvalho TG, Menard R: Manipulating the Plasmodium genome.

   Curr Issues Mol Biol 2005, 7(1):39-55. PubMed Abstract

9. Horrocks P, Lanzer M: Transfection of Plasmodium: A new chapter in the molecular analysis of malaria.

   Parasitol Int 1998, 47:101-106. Publisher Full Text

10. Dasaradhi PV, Mohmmed A, Kumar A, Hossain MJ, Bhatnagar RK, Chauhan VS, Malhotra P: A role of falcipain-2, principal cysteine proteases of Plasmodium falciparum in merozoite egression.

    Biochem Biophys Res Commun 2005, 336(4):1062-1068. PubMed Abstract | Publisher Full Text

11. Gissot M, Briquet S, Refour P, Boschet C, Vaquero C: PfMyb1, a Plasmodium falciparum transcription factor, is required for intra-erythrocytic growth and controls key genes for cell cycle regulation.

    J Mol Biol 2005, 346(1):29-42. PubMed Abstract | Publisher Full Text

12. Malhotra P, Dasaradhi PV, Kumar A, Mohmmed A, Agrawal N, Bhatnagar RK, Chauhan VS: Double-stranded RNA-mediated gene silencing of cysteine proteases (falcipain-1 and -2) of Plasmodium falciparum.

    Mol Microbiol 2002, 45(5):1245-1254. PubMed Abstract | Publisher Full Text

13. Ullu E, Tschudi C, Chakraborty T: RNA interference in protozoan parasites.

    Cell Microbiol 2004, 6(6):509-519. PubMed Abstract | Publisher Full Text

14. Miller LH, Baruch DI, Marsh K, Doumbo OK: The pathogenic basis of malaria.

    Nature 2002, 415(6872):673-679. PubMed Abstract | Publisher Full Text

15. Soldati D, Foth BJ, Cowman AF: Molecular and functional aspects of parasite invasion.

    Trends Parasitol 2004, 20(12):567-574. PubMed Abstract | Publisher Full Text

16. Gaur D, Mayer DC, Miller LH: Parasite ligand-host receptor interactions during invasion of erythrocytes by Plasmodium merozoites.

    Int J Parasitol 2004, 34(13-14):1413-1429. PubMed Abstract | Publisher Full Text

17. Adams JH, Blair PL, Kaneko O, Peterson DS: An expanding ebl family of Plasmodium falciparum.

    Trends Parasitol 2001, 17(6):297-299. PubMed Abstract | Publisher Full Text

18. Pasvol G: How many pathways for invasion of the red blood cell by the malaria parasite?

    Trends Parasitol 2003, 19:430-432. PubMed Abstract | Publisher Full Text

19. Vera-Bravo R, Valbuena JJ, Ocampo M, Garcia JE, Rodriguez LE, Puentes A, Lopez R, Curtidor H, Torres E, Trujillo M, Tovar DR, Patarroyo MA, Patarroyo ME: Amino terminal peptides from the Plasmodium falciparum EBA-181/JESEBL protein bind specifically to erythrocytes and inhibit in vitro merozoite invasion.

    Biochimie 2005, 87(5):425-436. PubMed Abstract | Publisher Full Text

20. Gilberger TW, Thompson JK, Triglia T, Good RT, Duraisingh MT, Cowman AF: A novel erythrocyte binding antigen-175 paralogue from Plasmodium falciparum defines a new trypsin-resistant receptor on human erythrocytes.

    J Biol Chem 2003, 278(16):14480-14486. PubMed Abstract | Publisher Full Text

21. Mayer DC, Mu JB, Kaneko O, Duan J, Su XZ, Miller LH: Polymorphism in the Plasmodium falciparum erythrocyte-binding ligand JESEBL/EBA-181 alters its receptor specificity.

    Proc Natl Acad Sci U S A 2004, 101(8):2518-2523. PubMed Abstract | Publisher Full Text | PubMed Central Full Text

22. Lanzillotti R, Coetzer TL: Myosin-like sequences in the malaria parasite Plasmodium falciparum bind human erythrocyte membrane protein 4.1.

    Haematologica 2004, 89(10):1168-1171. PubMed Abstract | Publisher Full Text

23. Lauterbach SB, Lanzillotti R, Coetzer TL: Construction and use of Plasmodium falciparum phage display libraries to identify host parasite interactions.

    Malar J 2003, 2(1):47. PubMed Abstract | BioMed Central Full Text | PubMed Central Full Text

24. Conboy JG: Structure, function, and molecular genetics of erythroid membrane skeletal protein 4.1 in normal and abnormal red blood cells.

    Semin Hematol 1993, 30(1):58-73. PubMed Abstract

25. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

    Anal Biochem 1987, 162(1):156-159. PubMed Abstract | Publisher Full Text

26. Conboy J, Kan YW, Shohet SB, Mohandas N: Molecular cloning of protein 4.1, a major structural element of the human erythrocyte membrane skeleton.

    Proc Natl Acad Sci U S A 1986, 83(24):9512-9516. PubMed Abstract | Publisher Full Text | PubMed Central Full Text

27. Conboy JG, Chan JY, Chasis JA, Kan YW, Mohandas N: Tissue- and development-specific alternative RNA splicing regulates expression of multiple isoforms of erythroid membrane protein 4.1.

    J Biol Chem 1991, 266(13):8273-8280. PubMed Abstract | Publisher Full Text

28. Waller KL, Nunomura W, An X, Cooke BM, Mohandas N, Coppel RL: Mature parasite-infected erythrocyte surface antigen (MESA) of Plasmodium falciparum binds to the 30-kDa domain of protein 4.1 in malaria-infected red blood cells.

    Blood 2003, 102(5):1911-1914. PubMed Abstract | Publisher Full Text

29. Trager W, Jensen JB: Human malaria parasites in continuous culture.

    Science 1976, 193(4254):673-675. PubMed Abstract | Publisher Full Text

30. Tyler JM, Reinhardt BN, Branton D: Associations of erythrocyte membrane proteins. Binding of purified bands 2.1 and 4.1 to spectrin.

    J Biol Chem 1980, 255(14):7034-7039. PubMed Abstract | Publisher Full Text

31. Cooke BM, Mohandas N, Coppel RL: Malaria and the red blood cell membrane.

    Semin Hematol 2004, 41(2):173-188. PubMed Abstract | Publisher Full Text

32. Walensky LD, Mohandas N, Lux SE: Disorders of the red blood cell membrane. In Blood: Principles and Practice of Hematology. Edited by: Handin RI, Lux SE, Stossel TP. Philadelphia , Lippincott; 2003:1709-1859.

33. Pasternack GR, Racusen RH: Erythrocyte protein 4.1 binds and regulates myosin.

    Proc Natl Acad Sci U S A 1989, 86(24):9712-9716. PubMed Abstract | Publisher Full Text | PubMed Central Full Text

34. Fowler VM, Davis JQ, Bennett V: Human erythrocyte myosin: identification and purification.

    J Cell Biol 1985, 100(1):47-55. PubMed Abstract | Publisher Full Text

35. Cibert C, Pruliere G, Lacombe C, Deprette C, Cassoly R: Calculation of a Gap restoration in the membrane skeleton of the red blood cell: possible role for myosin II in local repair.

    Biophys J 1999, 76(3):1153-1165. PubMed Abstract | Publisher Full Text | PubMed Central Full Text

36. Topolska AE, Wang L, Black CG, Coppel RL: Merozoite cell biology. In Malaria parasites: genomes and molecular biology. Edited by: Waters AP, Janse CJ. Wymondham, UK , Caister Academic Press; 2004.

37. Gilberger TW, Thompson JK, Reed MB, Good RT, Cowman AF: The cytoplasmic domain of the Plasmodium falciparum ligand EBA-175 is essential for invasion but not protein trafficking.

    J Cell Biol 2003, 162(2):317-327. PubMed Abstract | Publisher Full Text

38. Dowse T, Soldati D: Host cell invasion by the apicomplexans: the significance of microneme protein proteolysis.

    Curr Opin Microbiol 2004, 7(4):388-396. PubMed Abstract | Publisher Full Text

39. Singh N, Preiser P, Renia L, Balu B, Barnwell J, Blair P, Jarra W, Voza T, Landau I, Adams JH: Conservation and developmental control of alternative splicing in maebl among malaria parasites.

    J Mol Biol 2004, 343(3):589-599. PubMed Abstract | Publisher Full Text

40. Braun Breton C, Pereira da Silva LH: Malaria proteases and red blood cell invasion.

    Parasitol Today 1993, 9(3):92-96. PubMed Abstract | Publisher Full Text

41. Blackman MJ: Proteases involved in erythrocyte invasion by the malaria parasite: function and potential as chemotherapeutic targets.

    Curr Drug Targets 2000, 1(1):59-83. PubMed Abstract | Publisher Full Text

42. Preiser P, Kaviratne M, Khan S, Bannister L, Jarra W: The apical organelles of malaria merozoites: host cell selection, invasion, host immunity and immune evasion.

    Microbes Infect 2000, 2(12):1461-1477. PubMed Abstract | Publisher Full Text

43. PlasmoDB [http://www.plasmodb.org] webcite

    

Have something to say? Post a comment on this article!